BNET Industries

Genzyme Oncology Inc.

is in the Business Services Industry

Last Fiscal Year Sales:$34.7M

Private
US

Dow Jones Description

Genzyme Oncology is building a foundation in cancer treatment with a strong focus on discovery in both antibody and small molecule based therapies. Our lead products are Campath (alemtuzumab), a humanized monoclonal antibody and Clolar (clofarabine) a small molecule nucleoside analog. Ongoing discovery utilizes a broad range of target discovery, target validation and drug development technologies. Genzyme Oncology is also working in active collaboration with partner companies and academic institutions to identify and develop new therapies.

President, Oncology & Multiple Sclerosis

Mark J. Enyedy

Number of Employees 216

Contact Information

4545 Horizon Hill Blvd

San Antonio, Texas 78229

www.genzymeonco...

(210) 949-8200

Peer Companies

NAICS Code Research and Development in the Social Sciences and Humanities: 541720

Executive Profiles

Decision Makers

Name (plus bio)	Position
Mark J. Enyedy	President, Oncology & Multiple Sclerosis
Mark P. Mellin	CFO & Senior Vice President
Craig A. Tooman	Senior Vice President
Steven D. Weitman	Senior Vice President
Timothy M. Ruane	Senior Vice President, Business Management
Al Jecminek	Vice President, Licensing & Intellectual Property
Ian W.D. Clements	Vice President, Corp Development & Commercial Operations
Kenneth Burk	Vice President, Pharmaceutical Development
Ronald G. Tefteller	General Counsel & Vice President
Constance K. Wierman	Senior Director, Commercial Operations
Don York	Senior Director, Info Technology
John F. Barnes	Senior Director, HR
Terry L. Murdock	Senior Vice President & General Manager, Prod

Organization	Position	Status
Genzyme Oncology, Inc.	President, Oncology & Multiple Sclerosis	Current
Genzyme Corporation	Senior Vice President & President, Oncology & Multiple Sclerosis	Current

Organization	Position	Status
Genzyme Oncology, Inc.	CFO & Senior Vice President	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Senior Vice President	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Senior Vice President	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Senior Vice President, Business Management	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Vice President, Licensing & Intellectual Property	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Vice President, Corp Development & Commercial Operations	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Vice President, Pharmaceutical Development	Current

Organization	Position	Status
Genzyme Oncology, Inc.	General Counsel & Vice President	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Senior Director, Commercial Operations	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Senior Director, Info Technology	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Senior Director, HR	Current

Organization	Position	Status
Genzyme Oncology, Inc.	Senior Vice President & General Manager, Prod	Current

Executive News

FDA To Genzyme Corporation (GENZ) (JOBS): Cancer Trial Is 'Insufficient' 9/2/2009

BioSpace - 9/03/09 - View Story
FDA to Genzyme: Cancer trial is 'insufficient'

Boston Business Journal - 9/02/09 - View Story
UPDATE 3-U.S. panel rejects Genzyme leukemia drug study

Reuters - 9/01/09 - View Story
FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in...

Forbes.com - 9/01/09 - View Story
FDA Advisory Committee Recommends Randomized Trial to Support Proposed Indication for Clolar in Adult AML

Business Wire - 9/01/09 - View Story
FDA Advisory Committee to Discuss Genzymes Clolar for Adult AML on September 1

Business Wire - 8/28/09 - View Story